Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Valdoxan® - Agomelatine | 2014-03-19 | New contraindication for use and a reminder of importance of liver function monitoring. CLICK HERE |
|
| Roaccutane® - Isotretinoin | 2014-03-17 | Pregnancy Prevention Program and Safety Information about Roaccutane®. |
|
| VIREAD ® - Tenofovir | 2014-03-11 | Possible presence of silicone rubber in the above listed product and lots. |
|
| Gilenya® - Fingolimod | 2014-03-02 | Hemophagocytic syndrome (HPS) reported in patients treated with Gilenya®. |
|
| Zelboraf® - Vemurafenib | 2014-03-02 | Risk of liver injury reported with Zelboraf®. |
|
| Neupogen® - Filgrastim | 2014-01-26 | Risk of capillary leak syndrome in patients with cancer. |
|
| ZOFRAN® - Ondansetron | 2013-08-29 | Updated information on posology for intravenous use and dose dependant QT interval prolongation. |
|
| Diane-35® - Ethinylestradiol/Cyproterne | 2013-07-22 | Risk of Thromboembolism. |
|
| LARIAM® - Mefloquine | 2013-07-16 | Important Safety Update of Prescribing Information for LARIAM®.
|
|
| MabThera® - Rituximab | 2013-07-16 | The management of hepatitis B reactivation in patients treated with MabThera®. CLICK HERE |
|